- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Evolving Role of ADCs in HER2-Positive Breast Cancer: Clinical Integration from Early to Metastatic Disease
EP. 1: Evolving Horizons in HER2-Positive Breast Cancer Care
Discover how advancements in HER2-positive breast cancer treatment enhance patient outcomes through personalized therapies and innovative strategies for both early and metastatic stages.
Watch
EP. 2: Key HER2+ Patient Populations Evaluated in the DESTINY-Breast Program
Explore the latest advancements in HER2-positive breast cancer treatments, highlighting the promising results of DESTINY-Breast trials for improved patient outcomes.
Watch
EP. 3: Integrating Emerging DESTINY-Breast Data Into HER2+ Treatment Strategies
Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.
Watch
EP. 4: Interpreting Key Data From KATHERINE, HER2CLIMB-05, and PATINA
Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.
Watch
